News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biophage Pharma Inc. Awarded NRC-IRAP Funding to Develop Next Generation Biosensors


1/15/2008 3:34:53 PM

MONTREAL, Jan. 15 /CNW Telbec/ - (TSX.V: BUG). Biophage Pharma Inc. today announced that it has received confirmation of financial support from the National Research Council Industrial Research Assistance Program (NRC-IRAP) for the development of its next generation of PDS(R) Biosensors which will rapidly and specifically detect life threatening pathogens like Methicillin Resistant Staphylococcus Aureus (MRSA), Pseudomonas aeruginosa and E. coli O157.

Read at Canada NewsWire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES